Skip to main content
HISAMITSU PHARMACEUTICAL CO.,INC. logo

HISAMITSU PHARMACEUTICAL CO.,INC. — Investor Relations & Filings

Ticker · 4530 ISIN · JP3784600003 LEI · 5299006QL3IBQ4CN7E12 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2017-10-11 Interim / Quarterly Rep…
Country JP Japan
Listing T 4530

About HISAMITSU PHARMACEUTICAL CO.,INC.

https://global.hisamitsu/

Hisamitsu Pharmaceutical Co., Inc. is a pharmaceutical company that develops, manufactures, and markets a range of prescription and over-the-counter (OTC) products. The company specializes in external pain relief medications, utilizing advanced transdermal drug delivery system (TDDS) technology. Its core product portfolio includes topical analgesics and anti-inflammatory formulations, such as plasters, patches, and poultices. A key brand in its OTC segment is Salonpas, a globally recognized line of pain-relieving patches. The company serves both consumer healthcare and prescription markets worldwide, focusing on providing solutions for musculoskeletal pain and inflammation.

Recent filings

Filing Released Lang Actions
四半期報告書－第116期第2四半期(2017/06/01－2017/08/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains comprehensive financial statements, management analysis, and business information for the second quarter of the 116th fiscal period. This fits the definition of an Interim/Quarterly Report (IR). Q2 2018
2017-10-11 Japanese
四半期報告書－第116期第1四半期(2017/03/01－2017/05/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Hisamitsu Pharmaceutical Co., Inc. with the Kanto Local Finance Bureau in Japan. It covers the first quarter of the 116th fiscal period (March 1, 2017, to May 31, 2017). It contains detailed financial statements, management analysis of financial results, and information on shareholdings, which fits the definition of an Interim/Quarterly Report (IR). Q1 2018
2017-07-10 Japanese
有価証券報告書－第115期(2016/03/01－2017/02/28)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management indicators, and corporate information for the fiscal year ending February 28, 2017. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted under the Financial Instruments and Exchange Act. FY 2017
2017-05-26 Japanese
四半期報告書－第115期第3四半期(2016/09/01－2016/11/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains comprehensive financial statements, including the balance sheet and management analysis for the third quarter of the 115th fiscal period. It is not an announcement of a report, but the report itself, containing substantive financial data. 9M 2017
2017-01-13 Japanese
四半期報告書－第115期第2四半期(2016/06/01－2016/08/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the legal basis (Financial Instruments and Exchange Act). It contains comprehensive financial statements, management analysis, and business information for the second quarter of the 115th fiscal period. It is a formal, substantive financial report rather than an announcement or certification, fitting the definition of an Interim/Quarterly Report (IR). Q2 2016
2016-10-12 Japanese
四半期報告書－第115期第1四半期(2016/03/01－2016/05/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the legal basis (Financial Instruments and Exchange Act). It contains comprehensive financial statements, including the consolidated balance sheet, for the first quarter of the 115th fiscal period (March 1, 2016, to May 31, 2016). It includes detailed management analysis, financial data, and audit review information, fitting the definition of an Interim/Quarterly Report (IR). Q1 2017
2016-07-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.